Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug AdministrationGlobeNewsWire • 09/06/22
Spero Therapeutics, Inc. (SPRO) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 08/25/22
Spero Therapeutics, Inc. (SPRO) CEO Ankit Mahadevia on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/10/22
Spero Therapeutics Announces Second Quarter 2022 Operating Results and Provides Business UpdateGlobeNewsWire • 08/10/22
Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022GlobeNewsWire • 08/09/22
SHAREHOLDER ALERT FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spero Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SPROPRNewsWire • 07/25/22
SPRO FINAL DEADLINE TODAY: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important July 25 Deadline in Securities Class Action - SPRONewsfile Corp • 07/25/22
Bronstein, Gewirtz & Grossman, LLC Reminds Spero Therapeutics, Inc. (SPRO) Shareholders of Class Action Deadline and Last Few Hours to Actively ParticipateBusiness Wire • 07/25/22
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Spero Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/25/22
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Spero Investors of a Lead Plaintiff Deadline of July 25, 2022PRNewsWire • 07/25/22
Spero Class Action: Levi & Korsinsky Reminds Spero Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 25, 2022 - SPRONewsfile Corp • 07/22/22
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spero Therapeutics, Inc. (SPRO)Business Wire • 07/22/22
MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Spero Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/22/22
SPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero Shareholders of a Lead Plaintiff Deadline of July 25, 2022PRNewsWire • 07/22/22
Pomerantz Law Firm Announces the Filing of a Class Action Against Spero Therapeutics, Inc. and Certain Officers - SPROPRNewsWire • 07/21/22
SPRO Investors Have Opportunity to Lead Spero Therapeutics, Inc. Securities Fraud LawsuitPRNewsWire • 07/21/22
MONDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Spero Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/21/22
SPRO LAWSUIT ALERT: Levi & Korsinsky Notifies Spero Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 07/21/22
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Spero Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 25, 2022 - (NASDAQ: SPRO)PRNewsWire • 07/20/22
SPRO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 25, 2022 in the Class Action Filed on Behalf of Spero Therapeutics, Inc. ShareholdersPRNewsWire • 07/19/22
Spero Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 25, 2022 to Discuss Your Rights - SPRONewsfile Corp • 07/18/22
ROSEN, National Trial Lawyers, Encourages Spero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRONewsfile Corp • 07/15/22
